Page last updated: 2024-09-03

gefitinib and Depression

gefitinib has been researched along with Depression in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buiting, HM; de Kanter, W; Linn, SC; Smorenburg, CH1
Greer, J; Lynch, TJ; Pirl, WF; Sequist, L; Solis, J; Temel, JS1
Frantz, S1

Reviews

1 review(s) available for gefitinib and Depression

ArticleYear
[Living with incurable cancer].
    Nederlands tijdschrift voor geneeskunde, 2016, Volume: 160

    Topics: Aged; Anxiety; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Depression; Emotions; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Prognosis; Psychotherapy; Quality of Life; Quinazolines

2016

Other Studies

2 other study(ies) available for gefitinib and Depression

ArticleYear
Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Aug-10, Volume: 27, Issue:23

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Depression; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines

2009
Drug discovery: playing dirty.
    Nature, 2005, Oct-13, Volume: 437, Issue:7061

    Topics: Animals; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Clozapine; Depression; Drug Approval; Drug Design; Drug Evaluation, Preclinical; Drug Industry; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Piperazines; Pyrimidines; Quinazolines; Sensitivity and Specificity; Substrate Specificity; Therapeutics; United States; United States Food and Drug Administration

2005